A Phase 3 interventional study of Motivational interviewing in Psoriasis, sponsored by Oslo University Hospital. Status unknown at 2 sites in Norway. Open to participants aged 20 Years to 70 Years. Per ClinicalTrials.gov, last updated 2015-05-29.
Sponsored by Oslo University Hospital · Phase 3, Interventional, and Health services research
The aim of this study is to evaluate clinical and health economic parameters in relation to individual motivational counseling by phone.
A chronic condition such as psoriasis requires a high level of self- management and requires for many patients behaviour change to improve health outcome. Changing behaviour is a challenge that requires a commitment by the patient to implement successfully. Motivational interviewing is a patient centered directive counseling technique that focuses on assisting patients to identify their problems and involves exploring ambivalence in an empathic manner. It is a well-known method of counseling, and is considered to be a useful intervention strategy in the treatment of lifestyle problems.
This study is a randomized controlled trial using telephone motivational interviewing. The counseling intervention comprises 6 telephone calls during a 12 week period, after attending 3 weeks of supervised climate therapy on the Canary Islands
1,899 studies on the registry are indexed under Psoriasis; 233 are open to participants now.
This study's enrollment of 169 is above the median of 70 across 1,447 interventional studies indexed under Psoriasis.
Browse Psoriasis studies →Oslo University Hospital is the lead sponsor of 810 studies on the registry; 148 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Motivational interviewing
Behavioral: Motivational interviewing
Motivational interviewing technique will be used to improve patient adherence to multiple health behaviour changes and support patients with psoriasis to self- manage effectively. The intervention will discuss on four main topics: diet, physical activity, stress management and psoriasis treatment. Motivational interviewing is a patient centered directive counselling technique that focuses on assisting patients to identify their problems and involves exploring ambivalence in an empathic manner. A key goal in motivational interviewing is to increase the importance of change from the client's perspective. This is accomplished by using specific types of open ended questions, selective reflections and reflective listening.
SAPASI (+ PASI at T1 and T2)
The self-administered psoriasis area and severity index (SAPASI) is a structured instrument for measuring the severity of psoriasis.
Time frame: Change in SAPASI from baseline, to 3 weeks, 6 weeks and 12 weeks
HeiQ
The heiQ™ is an Australian-developed health education impact evaluation system. It consists of a set of eight scales. Each scale is an independent questionnaire and together they provide a comprehensive profile of the intended outcomes of health education / self-management programs.
Time frame: change from baseline to 3 months, 6 months
15D
The 15D is a generic, comprehensive (15-dimensional), self-administered instrument for measuring HRQoL among adults (age 16+ years).
Time frame: Change in 15D from baseline to 6 weeks and 12 weeks
Questionnaire about lifestyle
Questions about exercise, diet, stress, lifestyle change
Time frame: Change in lifestyle parametres from baseline to 6 weeks and 12 weeks
BIPQ-2
short questionnaire about illness perception
Time frame: Change from baseline to 3 and 6 months
Psoriasis Knowledge questionnaire
40 questions about psoriasis and psoriasis treatment
Time frame: change in knowledge from baseline to 3 weeks, 3 months and 6 monthts
Willingness to change to manage psoriasis
8 questions about plans for change or conducted change managing psoriasis symptoms
Time frame: change from baseline to 3 months and 6 months
This study is status unknown, as verified in Oct 2014. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Oslo University Hospital